| Conţinutul numărului revistei |
| Articolul precedent |
| Articolul urmator |
 |
 245 1 |
| Ultima descărcare din IBN: 2023-10-26 13:48 |
| Căutarea după subiecte similare conform CZU |
| 617.735-006.487-085.277-053.2 (1) |
| Științe medicale. Medicină (11491) |
 SM ISO690:2012БОБРОВА, Н., СОРОЧИНСКАЯ, Т.. Интравитреальная химиотерапия по новым методикам в органосохранном лечении ретинобластомы. In: Sănătate Publică, Economie şi Management în Medicină , 2022, nr. 1(92-S), pp. 96-99. ISSN 1729-8687. |
| EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
| Sănătate Publică, Economie şi Management în Medicină | ||||||
| Numărul 1(92-S) / 2022 / ISSN 1729-8687 /ISSNe 2587-3873 | ||||||
|
||||||
| CZU: 617.735-006.487-085.277-053.2 | ||||||
| Pag. 96-99 | ||||||
|
||||||
 Descarcă PDF |
||||||
| Rezumat | ||||||
A promising method of local CT is the intravitreal (IV) administration of cytostatics, of which melphalan is recognized as the most effective. IVCh allows the highest concentration of the chemotherapeutic agent to be obtained in the tissues of the eye with its minimum systemic concentration in the body, which reduces the risk of a general cytostatic side effect. 59 children were treated - 31 boys, 28 girls. The doses of melphalan and the time of administration were calculated according to tumor parameters. Indications have been developed for high-dose local chemotherapy (intravenous administration of melphalan at doses of 20 and 30 μg), which in combination with systemic chemoreduction and consolidation therapy has made it possible to save the eye in 92.3% of cases even with advanced T3 stages of retinoblastoma. |
||||||
| Cuvinte-cheie retinoblastoma, intravitreal chemotherapy, melphalan, ретинобластома, интравитреальная химиотерапия, мелфалан |
||||||
|
Crossref XML Export
<?xml version='1.0' encoding='utf-8'?> <doi_batch version='4.3.7' xmlns='http://www.crossref.org/schema/4.3.7' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd'> <head> <doi_batch_id>ibn-157710</doi_batch_id> <timestamp>1720031170</timestamp> <depositor> <depositor_name>Information Society Development Instiute, Republic of Moldova</depositor_name> <email_address>[email protected]</email_address> </depositor> <registrant>Asociaţia Economie, Management şi Psihologie în Medicină</registrant> </head> <body> <journal> <journal_metadata> <full_title>Sănătate Publică, Economie şi Management în Medicină </full_title> <issn media_type='print'>17298687</issn> </journal_metadata> <journal_issue> <publication_date media_type='print'> <year>2022</year> </publication_date> <issue>1(92-S)</issue> </journal_issue> <journal_article publication_type='full_text'><titles> <title>Интравитреальная химиотерапия по новым методикам в органосохранном лечении ретинобластомы</title> </titles> <contributors> <person_name sequence='first' contributor_role='author'> <given_name>Nadiya</given_name> <surname>Bobrova</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>T.</given_name> <surname>Sorocinskaia</surname> </person_name> </contributors> <publication_date media_type='print'> <year>2022</year> </publication_date> <pages> <first_page>96</first_page> <last_page>99</last_page> </pages> </journal_article> </journal> </body> </doi_batch>
|
|
|
